Treatment Patterns and Outcomes After Recurrence Following Adjuvant Nivolumab for Urothelial Carcinoma: An AGEHA Real-World Study.

Ogawa I, Narita T, Shinohara M, Kawashima Y, Sekine Y, Narita S, Kobayashi S, Abe N, Tazawa S, Fujita N, Mikami J, Okamoto T, Yamamoto H, Numakura K, Sato S, Habuchi T, Ohyama C, Hatakeyama S

Open source

DOI: 10.1111/iju.70636
Published: 2026 Sep
Container: International journal of urology : official journal of the Japanese Urological Association
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/iju.70636,
  title = {Treatment Patterns and Outcomes After Recurrence Following Adjuvant Nivolumab for Urothelial Carcinoma: An AGEHA Real-World Study.},
  author = {Ogawa I and Narita T and Shinohara M and Kawashima Y and Sekine Y and Narita S and Kobayashi S and Abe N and Tazawa S and Fujita N and Mikami J and Okamoto T and Yamamoto H and Numakura K and Sato S and Habuchi T and Ohyama C and Hatakeyama S},
  year = {2026},
  journal = {International journal of urology : official journal of the Japanese Urological Association},
  doi = {10.1111/iju.70636},
  url = {https://doi.org/10.1111/iju.70636}
}

RIS

TY  - JOUR
TI  - Treatment Patterns and Outcomes After Recurrence Following Adjuvant Nivolumab for Urothelial Carcinoma: An AGEHA Real-World Study.
AU  - Ogawa I
AU  - Narita T
AU  - Shinohara M
AU  - Kawashima Y
AU  - Sekine Y
AU  - Narita S
AU  - Kobayashi S
AU  - Abe N
AU  - Tazawa S
AU  - Fujita N
AU  - Mikami J
AU  - Okamoto T
AU  - Yamamoto H
AU  - Numakura K
AU  - Sato S
AU  - Habuchi T
AU  - Ohyama C
AU  - Hatakeyama S
PY  - 2026
JO  - International journal of urology : official journal of the Japanese Urological Association
DO  - 10.1111/iju.70636
UR  - https://doi.org/10.1111/iju.70636
ER  -

APA

I, O., T, N., M, S., Y, K., Y, S., S, N., S, K., N, A., S, T., N, F., J, M., T, O., H, Y., K, N., S, S., T, H., C, O., & S, H. (2026). Treatment Patterns and Outcomes After Recurrence Following Adjuvant Nivolumab for Urothelial Carcinoma: An AGEHA Real-World Study.. International journal of urology : official journal of the Japanese Urological Association. https://doi.org/10.1111/iju.70636

Source records

pubmed · retrieved 2026-09-26T05:01:27.213Z